Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) EPS (Basic) (2018 - 2025)

AVITA Medical's EPS (Basic) history spans 8 years, with the latest figure at -$0.37 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 15.91% year-over-year to -$0.37; the TTM value through Dec 2025 reached -$1.74, up 27.2%, while the annual FY2025 figure was -$1.74, 27.2% up from the prior year.
  • EPS (Basic) reached -$0.37 in Q4 2025 per RCEL's latest filing, up from -$0.46 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.38 in Q1 2022 to a low of -$0.73 in Q1 2024.
  • Average EPS (Basic) over 5 years is -$0.2, with a median of -$0.37 recorded in 2025.
  • Peak YoY movement for EPS (Basic): surged 136.62% in 2021, then tumbled 264.0% in 2023.
  • A 5-year view of EPS (Basic) shows it stood at $0.24 in 2021, then fell by 8.33% to $0.22 in 2022, then tumbled by 227.27% to -$0.28 in 2023, then crashed by 57.14% to -$0.44 in 2024, then rose by 15.91% to -$0.37 in 2025.
  • Per Business Quant, the three most recent readings for RCEL's EPS (Basic) are -$0.37 (Q4 2025), -$0.46 (Q3 2025), and -$0.38 (Q2 2025).